National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 16         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

   
Phase II, Phase I

   
UCSF-04458
NCT00227617

 
 
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

   
Phase II, Phase I

   
CTCT 06-11
NCT00493883

 
 
Lithium for Low-Grade Neuroendocrine Tumors

   
Phase II

   
CO07203
NIH R21CA117117-01A2, NCT00501540

 
 
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

   
Phase II

   
SOR-NET-001
NCT00605566

 
 
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

   
Phase II

   
2006-0954
NCT00607113

 
 
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

   
Phase II

   
07-162
NCT00610129

 
 
The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors

   
Phase II

   
CPTK787/ZK222584
NCT00627198

 
 
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

   
Phase II

   
C3-07-003
NCT00780663

 
 
The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases

   
Phase II

   
TASMC - 08 - BC - 270 - CTIL
NCT00781209

 
 
Multicenter Study of IMC-A12 in Combination With Depot Octreotide in Patients With Carcinoid or Islet Cell Cancer

   
Phase II

   
CP13-0710
NCT00781911

 
      1 2   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov